| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | BIRB 0796 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.083 | 0.2 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.062 | 0.2 |